Cellsonics

Cellsonics is a private, pre-revenue company pioneering an enzyme-free, acoustic wave-based tissue dissociation platform called SimpleFlow. Founded in 2017, the company addresses a critical bottleneck in single-cell analysis and cell therapy manufacturing by providing a gentler, faster, and potentially more representative method for creating single-cell suspensions. Its technology aims to improve cell yield, viability, and biological fidelity compared to traditional enzymatic methods, positioning it in the growing markets for research tools and therapeutic cell processing.

SimpleFlow: An acoustic wave-based, enzyme-free and heat-free platform for gentle tissue dissociation into single-cell suspensions.

Cellsonics competes with traditional enzymatic dissociation kits from major players like Miltenyi Biotec, STEMCELL Technologies, and Thermo Fisher. Its differentiation is its non-enzymatic, acoustic wave mechanism. It may also face future competition from other novel non-enzymatic dissociation technologies emerging in the research tools and cell processing space.